Beruflich Dokumente
Kultur Dokumente
Biomaterials
journal homepage: www.elsevier.com/locate/biomaterials
School of Pharmacy & Key Laboratory of Smart Drug Delivery, Fudan University, Shanghai 201203, China
State Key Laboratory of Molecular Engineering of Polymers & Department of Macromolecular Science, Fudan University, Shanghai 200433, China
Pancreatic Disease Institute, Department of Pancreatic Surgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China
d
Department of Integrative Oncology, Shanghai Cancer Center, Department of Oncology, Shanghai Medical University, Fudan University,
Shanghai 200032, China
b
c
a r t i c l e i n f o
a b s t r a c t
Article history:
Received 20 August 2014
Accepted 19 October 2014
Available online 15 November 2014
In this study, the photothermal effect of magnetic nanoparticle clusters was rstly reported for the
photothermal ablation of tumors both in vitro in cellular systems but also in vivo study. Compared with
individual magnetic Fe3O4 nanoparticles (NPs), clustered Fe3O4 NPs can result in a signicant increase in
the near-infrared (NIR) absorption. Upon NIR irradiation at 808 nm, clustered Fe3O4 NPs inducing higher
temperature were more cytotoxic against A549 cells than individual Fe3O4 NPs. We then performed
in vivo photothermal therapy (PTT) studies and observed a promising tumor treatment. Compared with
PBS and individual magnetic Fe3O4 NPs by NIR irradiation, the clustered Fe3O4 NPs treatment showed a
higher therapeutic efcacy. The treatment effects of clustered Fe3O4 NPs with different time of NIR
illumination were also evaluated. The result indicated that a sustained high temperature generated by
NIR laser with long irradiation time was more effective in killing tumor cells. Furthermore, histological
analysis of H&E staining and TUNEL immunohistological assay were further employed for antitumor
efcacy assessment of PTT against A549 tumors.
2014 Elsevier Ltd. All rights reserved.
Keywords:
Magnetic nanoparticle clusters
Fe3O4
Tumor
Photothermal therapy
1. Introduction
Nanomaterials have been extensively used in biomedical
research during the past twenty years [1e4]. Especially in recent
years, more and more studies focused on photo-absorbing nanoagents, and photothermal therapy (PTT) employing photoabsorbers
can convert optical energy into thermal energy to kill cancer cells
without affecting healthy tissues [5,6]. Compared with radiotherapy, chemotherapy and surgical management, PTT is less
invasive, controllable and highly efcient. Our and other research
groups have developed a large number of nanomaterials as PTT
agents, such as gold-based nanomaterials [5,7e9], carbon nanotubes and graphene [10,11], all of which show strong optical
absorbance in the near-infrared (NIR) tissue optical transparency
window. The previous results demonstrated that photoabsorberbased therapy might be a promising approach for cancer therapy,
68
temperature in nitrogen atmosphere, and NaOH solution (10 M, 50 mL) was then
slowly dropped into the ask from the dropping funnel in 1 h. After that, the mixture
was continuously stirred at room temperature for 1 h, which was then stirred at
90 C for another 2 h and cooled to room temperature under continuous stirring. The
whole process was in the nitrogen atmosphere. The products were washed with
deionized water three times, collected with the help of a magnet. After that, nitric
acid solution (2 M, 100 mL) was added into the above products, which were then
washed with deionized water several times and collected with the magnet, until the
pH value of the supernatant is neutral. Then 100 mL (0.3 M) of trisodium citrate was
added into the resulting products, the mixture was stirred for 30 min at 90 C in the
nitrogen atmosphere. Then it was cooled to room temperature, transferred into a
beaker and collected with the magnet, and 20 mL of deionized water and a lot of
acetone were added into the beaker to wash the products twice. Finally, the obtained
products were dispersed in 50 mL of deionized water, and stirred at 80 C for a long
time to remove acetone.
2.1. Materials
A549 cells were seeded in 96-well plates with a density of 104 cells/well, and
allowed to adhere for 24 h prior to assay. The cells were exposed to the clustered
magnetic NPs or individual magnetic NPs with the same concentration of 50 mg/mL,
respectively. The cells were or were not irradiated by NIR laser light at a power
density of 5 W/cm2 with different illumination time from 60 to 180 s. After the cells
were incubated at 37 C for another 24 h, they were incubated with 0.5 mg/mL MTT
in DMEM for 4 h in dark and then mixed with dimethyl sulfoxide after the supernatant was removed. The OD value at 570 nm was read using the microplate reader
(Synergy TM2, BIO-TEK Instruments Inc. USA). Cell viability was determined by the
percentage of OD value of the study group over the control group. Afterward, cells
were co-stained by a mixture of Calcein AM and PI solution for 20 min. The samples
were subjected to observe using a ZEISS LSM710 live cell confocal laser imaging
System (Carl Zeiss, German).
Iron (III) chloride (FeCl3$6H2O), iron (II) chloride (FeCl2$4H2O), trisodium citrate
dehydrate (C8H5Na3O7$2H2O), sodium acetate anhydrous (NaOAc), ethylene glycol
(EG), acetone, sodium hydroxide (NaOH), and nitric acid (HNO3) were purchased
from Shanghai Chemical Reagents Company (China). MTT (3-(4, 5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide) assay, and other biological reagents were
purchased from Invitrogen Corp. Dulbecco's modied Eagle medium (DMEM), Fetal
bovine serum (FBS), Penicillin-Streptomycin solution and Trypsin-EDTA solution
were purchased from Gibco (Tulsa, OK, USA). All the other chemicals were of
analytical grade, and puried water was produced by a Millipore water purication
system.
69
Fig. 1. TEM images of (a) individual magnetic Fe3O4 NPs and (b) clustered magnetic Fe3O4 NPs. (c) The XRD pattern of individual and clustered magnetic Fe3O4 NPs. (d) Magnetization loops of individual and clustered magnetic Fe3O4 NPs.
70
NPs has a nearly uniform size of ca. 225 nm with spherical shape
(Fig. 1b). A TEM image of the clustered Fe3O4 NPs at higher
magnication (Fig. S1) illustrates that the magnetite conglobulations are loose clusters, and the particles are composed of
nanocrystals with the size of about 5e10 nm. According to the
previously reported literature [44], these nanocrystals are connected with each other by amorphous matrix as a bridge. The
samples of individual and clustered Fe3O4 NPs both show similar
typical XRD patterns of magnetite (JCPDS no. 75-1609; Fig. 1c),
which indicates that the nanocrystalline structure of the clustered
Fe3O4 NPs is the same as individual Fe3O4 NPs. The magnetic
property characterization (Fig. 1d) shows that both individual and
clustered Fe3O4 NPs have superparamagnetic property and high
magnetization with saturation value of 58.69 emu/g for the individual Fe3O4 NPs, and 63.70 emu/g for the clustered Fe3O4 NPs,
respectively.
3.2. Photothermal effect of magnetic NPs
Fig. 2a illustrates the UVevis spectra of the individual and
clustered Fe3O4 NPs dispersed in deionized water. The individual
Fe3O4 NPs have a very weak absorption in the NIR spectroscopy
from 600 to 1000 nm. Surprisingly, the clustered Fe3O4 NPs show an
obvious absorption band containing a maximum at ca. 420 nm.
Moreover, compared with individual Fe3O4 NPs, the clustered Fe3O4
NPs also resulted in a signicant ~3.6 fold increase in the NIR absorption at 808 nm for the aggregation of nanoparticles. Thus, the
clustered Fe3O4 NPs that have a stronger absorption in the NIR
spectroscopy may be conducive to destroying tumors in vivo as an
effective thermal generator due to its in-depth tissue penetration.
The photothermal effects of the PBS solutions of the individual and
clustered Fe3O4 NPs were rstly examined and compared in vitro by
NIR laser irradiation (l 808 nm, 5 W/cm2). As seen from Fig. 2b,
the clustered Fe3O4 NPs were more efcient than the individual
Fe3O4 NPs in inducing a temperature increase with the same concentration and exposure time. For example, the temperature raised
by the clustered Fe3O4 NPs solution could reach 51.4 1.2 C with
the NPs concentration of 50 mg/mL and NIR exposure time of 180 s,
while that of the individual Fe3O4 NPs only reached 42.0 1.5 C.
Compared with the previous report using individual Fe3O4 NPs
with high concentration [29], the higher temperature was easily
acquirable by clustered Fe3O4 NPs with lower concentration and
shorter NIR irradiation time in our study, which was benecial for
the safe application in vivo. In addition, the NIR-heating effects of
the individual and clustered Fe3O4 NPs were both time and
concentration-dependent. The NPs with higher concentration
performed markedly better than that of low concentration. Likewise, the longer the laser irradiation time, the higher the solution
temperature is. The results indicate that optoelectronic excitation
of clustered Fe3O4 NPs by NIR irradiation can occur rapidly, and the
extra energies are efciently transferred into molecular vibration
modes to generate signicant amounts of thermal energy, which
could be useful as photothermal mediators.
In order to validate the feasibility of the Fe3O4 NPs in biomedicine, the nanomaterials of individual or clustered Fe3O4 NPs were
administered to A549 cells in 96-well plates, respectively, and each
group was subdivided into groups of with and without NIR laser
exposure. The cell counting Kit-8 (CCK-8) assay was employed for
the quantitative evaluation of cell viability [45]. The viability of
untreated cells was assumed to be 100%. The cell viability remained
about 92.63% when they were incubated with individual or clustered Fe3O4 NPs at higher concentration of 500 mg/mL for 24 h
(Fig. S2, Supporting information), which indicated our magnetic
nanomaterials had no inherent toxicity. Subsequently, the magnetic
nanomaterials were applied for the photothermal ablation of cancer cells. The cytotoxic effects by NIR irradiation were shown in
Fig. 3a. About 8.9%, 33.5% and 72.8% of cells were killed by clustered
Fe3O4 NPs at the concentration of 50 mg/mL with a power density of
5 W/cm2 for different illumination time of 60, 120 and 180 s,
respectively. And only 0.8%, 3.5% and 14.5% of cells were killed by
individual Fe3O4 NPs. In addition, direct irradiation of the cells
remained close to 100%, exhibiting no effect on cell viability. This is
mainly because the low light absorption by natural endogenous
cytochromes of these cells caused minimal temperature elevation
accounts for their high survival [5]. The CCK-8 experimental result
indicated that clustered Fe3O4 NPs inducing higher temperature
were more cytotoxic against A549 cells than individual Fe3O4 NPs
by NIR irradiation. These results also proved that cancer cells could
be effectively killed by clustered Fe3O4 NPs with lower concentration and shorter NIR irradiation time compared with previous
report [29]. Fluorescence images of calcein AM (green, live cells)
and PI (red, dead cells) co-stained cells after PTT were further
conrmed the effectiveness of PTT using clustered Fe3O4 NPs
(Fig. 3b). A large number of killed A549 cells were observed by
Fig. 2. (a) UVevis spectra of aqueous dispersion of individual and clustered magnetic Fe3O4 NPs. (b) The photothermal effects of the PBS solutions of individual and clustered
magnetic Fe3O4 NPs with the concentration of 0e80 mg/mL were examined ex vitro by irradiating NIR (l 808 nm, 5 W/cm2) for 60e180 s. Temperature was measured by
thermocouple.
71
Fig. 3. (a) Relative viabilities of PBS, individual and clustered magnetic Fe3O4 NPs with the concentration of 50 mg/mL treated A549 cells without or with NIR laser irradiation
(l 808 nm, 5 W/cm2) for 60e180 s. (b) Confocal uorescence images of calcein AM (green, live cells) and propidium iodide (red, dead cells) co-stained A549 cells treated by
clustered magnetic Fe3O4 NPs at the concentration of 50 mg/mL with NIR laser irradiation (l 808 nm, 5 W/cm2) for (1) 0 s, (2) 60 s, (3) 120 s, (4) 180 s. (c) Flow cytometry graphs of
A549 cells treated by clustered magnetic Fe3O4 NPs at the concentration of 50 mg/mL without or with NIR laser irradiation (l 808 nm, 5 W/cm2) for 180 s. The treated A549 cells
were double stained by Annexin-V-FITC/PI and analyzed by ow cytometry. Quadrant I doesn't representatively correspond to live or damaged cells; Quadrant II representatively
corresponds to the population of dying cells. The membranes of these cells had been compromised so PI could penetrate and then hybridize with their DNAs; Quadrant III represents
the population of live cells. Since the live cells have intact cell membranes, PI could not stain their DNAs; The population of dead cells, or stained DNAs, exhibits a high PI and small
forward scattering signal as shown in quadrant IV. These are free DNAs, no longer enclosed within a membrane. The analysis data reveal that cells targeted by the clustered
magnetic Fe3O4 NPs combined with NIR lighting display irreversible damage, as shown by the larger population in quadrant IV, where the cellular membrane is broken to such an
extent that the cell can no longer function nor recover from the damage [46].
72
Fig. 4. Infrared thermal images of PBS, individual and clustered magnetic Fe3O4 NPs with the concentration of 100 mg/mL injected A549 tumor sample under NIR laser irradiation
(l 808 nm, 5 W/cm2) for 0e180 s.
73
Fig. 5. (a) Tumor growth curves of different groups after treatment. Tumor sizes were measured every 2 days. Means and standard errors are shown. The groups of PBS, individual
magnetic Fe3O4 NPs with NIR irradiation for 180 s and clustered magnetic Fe3O4 NPs with NIR irradiation for 120 s were statistically identical. The antitumor efciency of clustered
magnetic Fe3O4 NPs with NIR irradiation for 180 s was particularly prominent and was superior to all the other groups (P < 0.05). (b) Body weight changes were recorded after
therapy every 2 days. Means and standard errors are shown. (c) Photograph of tumors after excision from PBS, individual and clustered magnetic Fe3O4 NPs under NIR irradiation.
(d) Tumor weights of each group. n.s. no signicant difference, *P < 0.05, **P < 0.01.
74
[5] Shen S, Tang HY, Zhang XT, Ren JF, Pang ZQ, Wang DG, et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy
with near-infrared radiation. Biomaterials 2013;34:3150e8.
[6] Shen S, Ren JF, Zhu XY, Pang ZQ, Lu XH, Deng CH, et al. Monodisperse magnetites anchored onto carbon nanotubes: a platform for cell imaging, magnetic manipulation and enhanced photothermal treatment of tumors. J Mater
Chem B 2013;1:1939e46.
[7] Okuno T, Kato S, Hatakeyama Y, Okajima J, Maruyama S, Sakamoto M, et al.
Photothermal therapy of tumors in lymph nodes using gold nanorods and
near-infrared laser light. J Control Release 2013;172:879e84.
[8] Tsai MF, Chang SH, Cheng FY, Shanmugam V, Cheng YS, Su CH, et al. Au
nanorod design as light-absorber in the rst and second biological nearinfrared windows for in vivo photothermal therapy. ACS Nano 2013;7:
5330e42.
[9] Bagley AF, Hill S, Rogers GS, Bhatia SN. Plasmonic photothermal heating of
intraperitoneal tumors through the use of an implanted near-infrared source.
ACS Nano 2013;7:8089e97.
[10] Robinson JT, Welsher K, Tabakman SM, Sherlock SP, Wang H, Luong R, et al.
High performance in vivo near-IR (>1 mum) imaging and photothermal
cancer therapy with carbon nanotubes. Nano Res 2010;3:779e93.
[11] Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, Kepic DP,
Arsikin KM, Jovanovic SP, et al. In vitro comparison of the photothermal
anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 2011;32:1121e9.
[12] Zhou ZG, Sun YA, Shen JC, Wei J, Yu C, Kong B, et al. Iron/iron oxide core/shell
nanoparticles for magnetic targeting MRI and near-infraredphotothermal
therapy. Biomaterials 2014;35:7470e8.
[13] Li XJ, Takashima M, Yuba E, Harada A, Kono K. PEGylated PAMAM dendrimerdoxorubicin conjugate-hybridized gold nanorod for combinedphotothermalchemotherapy. Biomaterials 2014;35:6576e84.
[14] Tao Y, Ju EG, Liu Z, Dong K, Ren JS, Qu XG. Engineered, self-assembled nearinfrared photothermal agents for combined tumor immunotherapy and
chemo-photothermal therapy. Biomaterials 2014;35:6646e56.
[15] Bai J, Liu YW, Jiang XE. Multifunctional PEG-GO/CuS nanocomposites for nearinfrared chemo-photothermal therapy. Biomaterials 2014;35:5805e13.
[16] Zhu MT, Nie GJ, Meng H, Xia T, Nel A, Zhao YL. Physicochemical properties
determine nanomaterial cellular uptake, transport, and fate. Acc Chem Res
2013;46:622e31.
[17] Nystrom AM, Fadeel B. Safety assessment of nanomaterials: implications for
nanomedicine. J Control Release 2012;161:403e8.
[18] Nel A, Xia T, Meng H, Wang X, Lin SJ, Ji ZX, et al. Nanomaterial toxicity testing
in the 21st century: use of a predictive toxicological approach and highthroughput screening. Acc Chem Res 2013;46:607e21.
[19] Li WP, Liao PY, Su CH, Yeh CS. Formation of oligonucleotide-gated silica shellcoated Fe3O4-Au coreeshell nanotrisoctahedra for magnetically targeted and
near-infrared light-responsive theranostic platform. J Am Chem Soc
2014;136:10062e75.
[20] Torres-Lugo M, Rinaldi C. Thermal potentiation of chemotherapy by magnetic
nanoparticles. Nanomedicine 2013;8:1689e707.
[21] Dormer KJ, Awasthi V, Galbraith W, Kopke RD, Chen K, Wassel R. Magnetically-targeted, technetium 99m-labeled nanoparticles to the inner ear.
J Biomed Nanotechnol 2008;4:174e84.
[22] Gogoi M, Sarma HD, Bahadur D, Banerjee R. Biphasic magnetic nanoparticlesnanovesicle hybrids for chemotherapy and self-controlled hyperthermia.
Nanomedicine 2014;9:955e70.
[23] Shi DL, Cho HS, Chen Y, Xu H, Gu HC, Lian J. Adv Mater 2009;21:2170e3.
[24] Storm FK, Harrison WH, Elliott RS, Morton DL. Cancer Res 1979;39:2245e51.
[25] Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, et al. Efcacy
and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with
recurrent glioblastoma multiforme. J Neurooncol 2011;103:317e24.
[26] Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, et al.
Intracranial thermotherapy using magnetic nanoparticles combined with
external beam radiotherapy: results of a feasibility study on patients with
glioblastoma multiforme. J Neurooncol 2007;81:53e60.
fner N,
[27] Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldo
et al. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur Urol
2007;52:1653e61.
fner N, Scholz R,
[28] Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldo
et al. Morbidity and quality of life during thermotherapy using magnetic
nanoparticles in locally recurrent prostate cancer: results of a prospective
phase I trial. Int J Hyperth 2007;23:315e23.
[29] Chu MQ, Shao YX, Peng JL, Dai XY, Li HK, Wu QS, et al. Near-infrared laser light
mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles. Biomaterials 2013;34:4078e88.
vy M, Bacri JC, et al.
[30] Lartigue L, Hugounenq P, Alloyeau D, Clarke SP, Le
Cooperative organization in iron oxide multi-core nanoparticles potentiates
their efciency as heating mediators and MRI contrast agents. ACS Nano
2012;6:10935e49.
[31] Qiu P, Jensen C, Charity N, Towner R, Mao C. Oil phase evaporation-induced
self-assembly of hydrophobic nanoparticles into spherical clusters with
controlled surface chemistry in an oil-in-water dispersion and comparison of
behaviours of individual and clustered iron oxide nanoparticles. J Am Chem
Soc 2010;132:17724e32.
[32] Hayashi K, Nakamura M, Sakamoto W, Yogo T, Miki H, Ozaki S, et al. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 2013;3:
366e76.
[33] Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, et al.
Magnetically responsive smart nanoparticles for cancer treatment with a
combination of magnetic hyperthermia and remote-control drug release.
Theranostics 2013;4:834e44.
[34] Qin W, Lohrman J, Ren SQ. Magnetic and optoelectronic properties of gold
nanocluster-thiophene assembly. Angew Chem Int Ed 2014;53:7316e9.
[35] Ni WX, Qiu YM, Li M, Zheng J, Sun RWY, Zhan SZ, et al. Metallophilicity-driven
dynamic aggregation of a phosphorescent gold(I)-ailver(I) cluster prepared by
aolution-based and mechanochemical approaches. J Am Chem Soc 2014;136:
9532e5.
[36] Zhang XD, Chen J, Luo ZT, Wu D, Shen X, Song SS, et al. Enhanced tumor
accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy. Adv
Health Mater 2014;3:133e41.
[37] Retnakumari A, Jayasimhan J, Chandran P, Menon D, Nair S, Mony U, et al.
CD33 monoclonal antibody conjugated Au cluster nano-bioprobe for targeted
ow-cytometric detection of acute myeloid leukaemia. Nanotechnology
2011;22:285102.
[38] Deng YH, Yang WL, Wang CC, Fu SK. A novel approach for preparation of
thermoresponsive polymer magnetic microspheres with coreeshell structure.
Adv Mater 2003;15:1729e32.
[39] Ma W, Xu S, Li JM, Guo J, Lin Y, Wang CC. Hydrophilic dual-responsive
magnetite/PMAA core/shell microspheres with high magnetic susceptibility
and pH sensitivity via distillation-precipitation polymerization. J Polym Sci
Part A Polym Chem 2011;49:2725e33.
[40] Ren JF, Shen S, Wang DG, Xi Z, Guo LR, Pang ZQ, et al. The targeted delivery of
anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon
nanotubes modied with angiopep-2. Biomaterials 2012;33:3324e33.
[41] Zhang B, Sun X, Mei H, Wang Y, Liao Z, Chen J, et al. LDLR-mediated peptide22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Biomaterials 2013;34:9171e82.
[42] Zhang B, Shen S, Liao Z, Shi W, Wang Y, Zhao J, et al. Targeting bronectins of
glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles. Biomaterials 2014;35:4088e98.
[43] Zhang B, Wang H, Liao Z, Wang Y, Hu Y, Yang J, et al. EGFP-EGF1-conjugated
nanoparticles for targeting both neovascular and glioma cells in therapy of
brain glioma. Biomaterials 2014;35:4133e45.
[44] Liu J, Sun Z, Deng Y, Zou Y, Li C, Guo X, et al. Highly water-dispersible
biocompatible magnetite particles with low cytotoxicity stabilized by citrate
groups. Angew Chem Int Ed 2009;48:5875e9.
[45] Wang S, Zhang Q, Luo XF, Li J, He H, Yang F, et al. Magnetic graphene-based
nanotheranostic agent for dual-modality mapping guided photothermal
therapy in regional lymph nodal metastasis of pancreatic cancer. Biomaterials
2014;35:9473e83.
[46] Au L, Zheng D, Zhou F, Li ZY, Li XD, Xia YN. A quantitative study on the
photothermal effect of immuno gold nanocages targeted to breast cancer
cells. ACS Nano 2008;2:1645e52.
[47] Zhou YF. Noninvasive treatment of breast cancer using high-intensity focused
ultrasound. J Med Imaging Health Informatics 2013;3:141e56.